COMPARISON OF MALE AND FEMALE BREAST CANCER CHARACTERISTICS IN SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS PROGRAM REGISTRIES

Abstract

The prevalence and incidence of breast cancer in today's era is a remarkable health concern in both sexes. Male breast cancer constitutes a small fraction of reported cases but its impact should not be underestimated. The escalating number of male breast cancer and its distinctive characteristics call for a comprehensive analogy with its female counterpart. The purpose of this study is to conduct comparative analysis of male and female breast cancer, focusing on various variable factors such as race, age, and Surveillance, Epidemiological, and End Results Program (SEER) historical stage and to make a substantial difference to the broader understanding of breast cancer. This study was conducted under the approach of observational and retrospective study entailing 2021–2022-year cases from SEER registries of 9, 13, and 17. The key variables examined in the study are age, race, tumor size, and lymph node. The results showed that reported cases of male breast cancer are almost 1% around the world. The study includes 5494 male cases (0.7%) and 835,805 female cases (99.3%). The investigation's findings highlight that the mean age of males with breast cancer is 65.8 years. They also have low-grade tumors and a higher incidence of estrogen receptor positivity in comparison to females. Clearly, variations in attributes are noticeable amidst diverse categories, emphasizing the requirement for directed interventions. This research highlights the infrequency of male breast cancer occurrences, demonstrating the necessity for further investigation to enhance early detection and treatment. The discoveries of the inquiry supplement the broader appreciation of breast cancer and furnish acuities into potential fields for enhancing patient care.